Remove BioTech Remove Leadership Remove Strategy
article thumbnail

EVERSANA Expands Global Commercialisation Capabilities and Strengthens Agency Network with Healthware Group Acquisition

Digital Health Global

The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges. Financial details of the acquisition are not being disclosed.

article thumbnail

Koneksa Announces Expanded Partnership with SSI Strategy to Scale the Adoption of Digital Biomarkers in Clinical Trials

Digital Health Global

As part of the partnership, SSI will expand Koneksa’s medical strategy division, especially in translational and clinical drug development. We look for similar customer-oriented ethos and patient-centric mindsets in our partnerships,” said Kim Kushner, Chief Business Officer, SSI Strategy. Learn more at koneksahealth.com.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Doximity - the 'Linkedin for Doctors' is the best performing healthcare stock in 2025

Lloyd Price

While giants like UnitedHealth or biotech stars like Vertex Pharmaceuticals often dominate headlines, Doximitys niche focus and execution have propelled it ahead. Healthcare Technology Thought Leadership from Nelson Advisors Market Insights, Analysis & Predictions.

article thumbnail

HealthTech M&A Multiples March 2025: Current Trends and Variables driving valuations

Lloyd Price

Big Pharmas looming patent cliffs could drive outlier deals (7-8x or more) for late-stage innovators, especially in biotech-adjacent HealthTech. Healthcare Technology Thought Leadership from Nelson Advisors Market Insights, Analysis & Predictions. This is down from 6.5x

article thumbnail

Accenture Invests in QuantHealth to Accelerate Use of AI-Powered Clinical Trial Simulations to Drive Cost-Effective Drug Development

Healthcare IT Today

Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients.

article thumbnail

Wound Care: Emerging HealthTech market to watch in 2025

Lloyd Price

The increasing prevalence of these conditions is driving demand for innovative solutions and improved management strategies. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Natural-Based Therapies: Honey: Honey has antimicrobial properties and can promote wound healing.

article thumbnail

Supreme Group Acquires Health+Commerce, an Integrated Marketing and Public Relations Agency Serving Innovative Healthcare Companies

Digital Health Global

“In only seven years, Health+Commerce has built a highly respected organization providing strategic programs that reach clinician, investor and consumer audiences in the multibillion-dollar medtech, biotech and digital health sectors. We look forward to supporting the agency as it continues on its growth trajectory.”